Pipeline

Early Detection saves lives

Lung cancer has the LOWEST 5-year survival rate
Lung cancer is a leading cause of all cancer related deaths worldwide due to the difficulty of diagnosis at an early stage because it rarely shows obvious symptoms. The more lung cancer becomes advanced, the poor prognosis it shows. The way to increase survival rate of lung cancer patient is effective early cancer detection, when it can most easily treated.

01 Product Overview

  • In-vitro diagnostics for early lung cancer diagnostics with 3 multivariate serum protein biomarkers.
  • Beads Microarray platform(Luminex)
  • Provides the test result from its analysis program.
  • Provides lung cancer risk information(high risk/low risk) in a score form from 0 to 1.

02 Test Procedures

03 Clinical Performance Verification

LC-Check was clinically validated in early stage cancer.